WASHINGTON — With recent data from the FREEDOM and SYNTAX trials showing improved rates of mortality and MI in patients with advanced CAD treated with CABG compared with PCI, many interventionalists are left questioning the role of stenting in the future management of this patient population.
However, the decision of whether to perform stenting or surgery in the setting of advanced CAD requires unbiased judgment and necessitates factoring in more variables than just mortality and MI, according to David Holmes, MD, of the Mayo Clinic.
More »